Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atorvastatin Dose Effects on Vulnerable Coronary Plaques by OCT
ChiCTR-IPR-17010874Phase 4Completed
- Sponsor
- First Affiliated Hospital of Ningbo University
- Start
- Jun 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of atorvastatin in acute coronary syndrome (ACS) (2 arms), sponsored by First Affiliated Hospital of Ningbo University. Primary endpoint: Fibrous cap thickness. Started Jun 2012; status: completed.
02
Drugs
atorvastatin
03
Conditions
acute coronary syndrome (ACS)
Beyond the preview
Go deeper on ChiCTR-IPR-17010874.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-17010874.